Paper9596703
Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance.
Norris KA. Infect Immun, 1998. Cited by 53 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Papers, record 9596703. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9596703
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Activation | Major topic |
| Complement Inactivator Proteins | Major topic |
| Membrane Glycoproteins | Major topic |
| Protozoan Proteins | Major topic |
| Trypanosoma cruzi | Major topic |
| Animals | |
| Cell Differentiation | |
| Complement C3b | |
| DNA, Complementary | |
| Drug Resistance | |
| Gene Expression | |
| Genetic Vectors | |
| Humans | |
| Polymerase Chain Reaction | |
| Protein Binding | |
| Recombinant Proteins | |
| Transfection |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI032719 | NIAID NIH HHS | United States | R01AI032719 | PubMed and NIH | NIH RePORTER |
| AI32719 | NIAID NIH HHS | United States | R01AI032719 | PubMed and NIH | NIH RePORTER |
| R29AI032719 | NIH | NIH RePORTER |
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 46840 | Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi. | Infect Immun | 1975 | https://conductscience.org/library/papers/46840 | PubMed |
| 2 | 9009282 | Identification of the gene family encoding the 160-kilodalton Trypanosoma cruzi complement regulatory protein. | Infect Immun | 1997 | https://conductscience.org/library/papers/9009282 | PubMed |
| 3 | 815433 | Protective effects of specific antibodies in Trypanosoma cruzi infections. | J Immunol | 1976 | https://conductscience.org/library/papers/815433 | PubMed |
| 4 | 6992059 | The growth of Trypanosoma cruzi in human diploid cells for the production of trypomastigotes. | Parasitology | 1980 | https://conductscience.org/library/papers/6992059 | PubMed |
| 5 | 6801127 | Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies. | J Immunol | 1982 | https://conductscience.org/library/papers/6801127 | PubMed |
| 6 | 6207242 | Cryptic epitope explains the failure of a monoclonal antibody to bind to certain isolates of Trypanosoma cruzi. | J Immunol | 1984 | https://conductscience.org/library/papers/6207242 | PubMed |
| 7 | 3042767 | Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. | J Biol Chem | 1988 | https://conductscience.org/library/papers/3042767 | PubMed |
| 8 | 2973433 | gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway. | Immunology | 1988 | https://conductscience.org/library/papers/2973433 | PubMed |
| 9 | 2663722 | Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies. | Infect Immun | 1989 | https://conductscience.org/library/papers/2663722 | PubMed |
| 10 | 2504665 | The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies. | Immunol Lett | 1989 | https://conductscience.org/library/papers/2504665 | PubMed |
| 11 | 1717552 | Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. | J Immunol | 1991 | https://conductscience.org/library/papers/1717552 | PubMed |
| 12 | 1324472 | A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania. | Nucleic Acids Res | 1992 | https://conductscience.org/library/papers/1324472 | PubMed |
| 13 | 7688032 | FL-160 proteins of Trypanosoma cruzi are expressed from a multigene family and contain two distinct epitopes that mimic nervous tissues. | J Exp Med | 1993 | https://conductscience.org/library/papers/7688032 | PubMed |
| 14 | 8262633 | Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi. | Infect Immun | 1994 | https://conductscience.org/library/papers/8262633 | PubMed |
| 15 | 8063427 | Humoral immune response to the Trypanosoma cruzi complement regulatory protein as an indicator of parasitologic clearance in human Chagas' disease. | Infect Immun | 1994 | https://conductscience.org/library/papers/8063427 | PubMed |
| 16 | 8905613 | Ligand-binding renders the 160 kDa Trypanosoma cruzi complement regulatory protein susceptible to proteolytic cleavage. | Microb Pathog | 1996 | https://conductscience.org/library/papers/8905613 | PubMed |
| 17 | 807672 | Studies on the selective lysis and purification of Trypanosoma cruzi. | J Exp Med | 1975 | https://conductscience.org/library/papers/807672 | PubMed |
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42429568 | Glycocalyx-Driven Immunomodulation in Trypanosoma cruzi: Structures, Host Responses, Diagnostic and Therapeutic Targeting. | Parasite Immunol | 2026 | https://conductscience.org/library/papers/42429568 | PubMed |
| 41810676 | Transcriptomic dynamics reveals sequential acquisition of complement resistance during prolonged starvation of Trypanosoma cruzi epimastigote | Mem Inst Oswaldo Cruz | 2026 | https://conductscience.org/library/papers/41810676 | PubMed |
| 41568009 | Towards a map of the immune system manipulation network by Trypanosoma cruzi. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41568009 | PubMed |
| 41187580 | The grand escape - how pathogens outsmart the human complement system. | Immunobiology | 2025 | https://conductscience.org/library/papers/41187580 | PubMed |
| 38239357 | Microbial evasion of the complement system: a continuous and evolving story. | Front Immunol | 2023 | https://conductscience.org/library/papers/38239357 | PubMed |
| 36590580 | An induced population of Trypanosoma cruzi epimastigotes more resistant to complement lysis promotes a phenotype with greater differentiation, invasiveness, and release of extracellular vesicles. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36590580 | PubMed |
| 35401838 | Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics. | Theranostics | 2022 | https://conductscience.org/library/papers/35401838 | PubMed |
| 34975884 | Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System? | Front Immunol | 2021 | https://conductscience.org/library/papers/34975884 | PubMed |
| 34778110 | Impact of the Extracellular Vesicles Derived From Trypanosoma cruzi: A Paradox in Host Response and Lipid Metabolism Modulation. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34778110 | PubMed |
| 33720977 | Deletion of a Golgi protein in Trypanosoma cruzi reveals a critical role for Mn2+ in protein glycosylation needed for host cell invasion and intracellular replication. | PLoS Pathog | 2021 | https://conductscience.org/library/papers/33720977 | PubMed |
| 32793217 | The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence. | Front Immunol | 2020 | https://conductscience.org/library/papers/32793217 | PubMed |
| 31907197 | Induction of Effective Immunity against Trypanosoma cruzi. | Infect Immun | 2020 | https://conductscience.org/library/papers/31907197 | PubMed |
| 30949145 | Complement Evasion: An Effective Strategy That Parasites Utilize to Survive in the Host. | Front Microbiol | 2019 | https://conductscience.org/library/papers/30949145 | PubMed |
| 29513875 | Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi. | Mem Inst Oswaldo Cruz | 2018 | https://conductscience.org/library/papers/29513875 | PubMed |
| 29434593 | Leishmania donovani Inhibitor of Serine Peptidases 2 Mediated Inhibition of Lectin Pathway and Upregulation of C5aR Signaling Promote Parasite Survival inside Host. | Front Immunol | 2018 | https://conductscience.org/library/papers/29434593 | PubMed |
| 28919885 | Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28919885 | PubMed |
| 28473804 | The Complement System: A Prey of Trypanosoma cruzi. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28473804 | PubMed |
| 28286708 | Transcriptomic analysis reveals metabolic switches and surface remodeling as key processes for stage transition in Trypanosoma cruzi. | PeerJ | 2017 | https://conductscience.org/library/papers/28286708 | PubMed |
| 27047464 | Role of Trypanosoma cruzi Trans-sialidase on the Escape from Host Immune Surveillance. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27047464 | PubMed |
| 26834737 | Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection. | Front Immunol | 2015 | https://conductscience.org/library/papers/26834737 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| C4B | 721 | PubTator's text mining | https://conductscience.org/library/genes/721 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9596703
GET https://conductscience.org/api/papers/v1/9596703/cited_by?page=2